Table 1. Clinical characteristics of... | American Society of Hematology

Table 1.

Clinical characteristics of healthy donors and hospitalized patients with COVID-19

Characteristics	Healthy donors (n = 17)	Hospitalized		P
Characteristics	Healthy donors (n = 17)	Non-ICU COVID-19 infection (n = 19)	ICU COVID-19 infection (n = 14)	P
Age, mean ± SD, y	50.6 ± 17.6	48.2 ± 13.6	64.5 ± 13.7	.008
Male	50	52.6	57.1	.94
Hispanic/Latino/African American	11.8	31.6	42.9	.15
BMI (kg/m²), mean ± SD		33.9 ± 9.6	30.5 ± 9.4	.43
Diabetes		31.6	57.1	.15
Hypertension		36.8	42.9	.74
Chronic lung disease		26.3	42.9	.33
SOFA score, mean ± SD		1.6 ± 1.3	4.6 ± 1.2	<.0001
ARDS		10.5	92.9	<.0001
Mechanical ventilation		0.0	50.0	<.0001
28-d survival		100	71.4	.011
WBC (k/uL), mean ± SD		6.1 ± 2.4	8.3 ± 2.3	.02
Platelet count (k/uL), mean ± SD		245 ± 107	244 ± 56	.97

Characteristics	Healthy donors (n = 17)	Hospitalized		P
Characteristics	Healthy donors (n = 17)	Non-ICU COVID-19 infection (n = 19)	ICU COVID-19 infection (n = 14)	P
Age, mean ± SD, y	50.6 ± 17.6	48.2 ± 13.6	64.5 ± 13.7	.008
Male	50	52.6	57.1	.94
Hispanic/Latino/African American	11.8	31.6	42.9	.15
BMI (kg/m²), mean ± SD		33.9 ± 9.6	30.5 ± 9.4	.43
Diabetes		31.6	57.1	.15
Hypertension		36.8	42.9	.74
Chronic lung disease		26.3	42.9	.33
SOFA score, mean ± SD		1.6 ± 1.3	4.6 ± 1.2	<.0001
ARDS		10.5	92.9	<.0001
Mechanical ventilation		0.0	50.0	<.0001
28-d survival		100	71.4	.011
WBC (k/uL), mean ± SD		6.1 ± 2.4	8.3 ± 2.3	.02
Platelet count (k/uL), mean ± SD		245 ± 107	244 ± 56	.97

Unless otherwise noted, data are percentages (%).

BMI, body mass index; SOFA, Sequential Organ Failure Assessment; WBC, white blood cell count.